Tag Archives: patients

New tool could predict future cardiac health status for patients

Precision Wellness in Silicon Valley has validated a cardiometabolic disease predictive risk engine to accurately predict an individual’s future state of health. The study was performed as part of sponsored precision medicine research with Stanford University to evaluate nearly 417,000 individuals from a United Kingdom Biobank population that was tracked for six years. Risk models… Read More »

FDA Approves Lonsurf (trifluridine/tipiracil) for Adult Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Print this page PRINCETON, N.J., February 25, 2019 – Taiho Oncology, Inc. today announced that the United States Food and Drug Administration (FDA) has approved Lonsurf as a treatment for adult patients with metastatic gastric or gastroesophageal junction adenocarcinoma previously treated with at least two prior lines of chemotherapy that included a fluoropyrimidine, a platinum,… Read More »